Literature DB >> 16747184

Immunological differences of crystalline Bence-Jones proteins.

L Hektoen1, W H Welker.   

Abstract

Year:  1940        PMID: 16747184      PMCID: PMC1265304          DOI: 10.1042/bj0340487

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  11 in total

1.  Further studies of the gamma-related proteins of normal urine.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  The biological significance of the anomalous serum and urinary proteins of myelomatosis, lymphoma, and other conditions.

Authors:  J A OWEN; C GOT
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

3.  [Amino acids composing Bence-Jones proteines].

Authors:  K SCHREIER; H PLUCKTHUN
Journal:  Klin Wochenschr       Date:  1952-08-01

4.  Serum Proteins: A Review.

Authors:  J R Marrack; H Hoch
Journal:  J Clin Pathol       Date:  1949-08       Impact factor: 3.411

5.  The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease.

Authors:  C E Dent; G A Rose
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

6.  BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA.

Authors:  D H Moore; E A Kabat; A B Gutman
Journal:  J Clin Invest       Date:  1943-01       Impact factor: 14.808

7.  ON THE PATHOGENESIS OF RENAL FAILURE ASSOCIATED WITH MULTIPLE MYELOMA. ELECTROPHORETIC AND CHEMICAL ANALYSIS OF PROTEIN IN URINE AND BLOOD SERUM.

Authors:  S S Blackman; W H Barker; M V Buell; B D Davis
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

8.  TWO TYPES OF gamma-MYELOMA PROTEINS, beta(2A)-MYELOMA PROTEINS, gamma(1)-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS.

Authors:  J L Fahey; A Solomon
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

9.  Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.

Authors:  R W RUNDLES; G R COOPER; R W WILLETT
Journal:  J Clin Invest       Date:  1951-10       Impact factor: 14.808

10.  Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.

Authors:  R W RUNDLES; M L DILLON; E S DILLON
Journal:  J Clin Invest       Date:  1950-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.